文献速递肾小球疾病

肾三级淋巴组织与IgA肾病免疫抑制反应不佳相关

Kidney Tertiary Lymphoid Tissues and Poor Immunosuppressive Response in IgA Nephropathy.
PubMed 文献 · Kidney Int Rep · 2025-11-17

这项前瞻性队列研究纳入845例经优化支持治疗后仍蛋白尿≥1 g/d的中国IgA肾病患者,免疫抑制中位22个月。肾间质三级淋巴组织(TLT)见于50.8%患者,其存在及分期与免疫抑制反应不佳风险显著升高相关,联合临床与肾小球巨噬细胞数据可提升预测效能。

要点

  • IgA肾病患者肾间质TLT检出率为50.8%,晚期(II/III期)占16.8%。
  • TLT存在及分期越高,免疫抑制反应不佳风险越高,晚期调整OR达6.25。
  • TLT分期联合临床与肾小球巨噬细胞数据预测反应不佳AUC达0.90。

核心结论

  • 诊断时肾间质TLT存在与IgA肾病患者免疫抑制反应不佳相关。

研究设计与样本

  • 前瞻性队列研究纳入845例中国IgA肾病患者,经3个月优化支持治疗(RAS抑制剂)后蛋白尿≥1 g/d,接受免疫抑制中位22个月。
  • 肾间质TLT经免疫组化计数并分期:I期无滤泡树突状细胞(FDC),II期有FDC,III期有生发中心(GC)。

主要发现

  • 845例中429例(50.8%)存在肾间质TLT,其中72例(16.8%)为晚期(II或III期)。
  • 与无TLT者相比,任何分期TLT、I期TLT、晚期TLT的免疫抑制反应不佳调整OR(95%CI)分别为3.07(2.16-4.37)、2.97(2.05-4.28)、6.25(3.39-11.53)。
  • TLT分期与数量预测免疫抑制反应不佳的AUC为0.81(95%CI:0.75-0.87)。
  • TLT联合活检时临床与肾小球巨噬细胞数据后AUC升至0.90(95%CI:0.87-0.94)。

临床怎么用

  • 对拟接受免疫抑制治疗的IgA肾病患者,肾活检评估肾间质TLT及其分期可能有助于识别反应不佳的高风险人群。
  • TLT联合临床与肾小球巨噬细胞数据可提升对免疫抑制反应不佳的预测效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ectopic lymphoid structures termed as tertiary lymphoid tissues (TLTs) are observed in certain kidney diseases, including IgA nephropathy (IgAN); however, clinical relevance of TLTs remains unclear. METHODS: This prospective cohort study included 845 Chinese patients with IgAN with proteinuria ≥ 1 g/d despite 3 months of optimized supportive care with renin-angiotensin system inhibitors. Patients received immunosuppression for a median of 22 months. Kidney interstitial TLTs, defined as lymphocyte aggregates, were counted using immunochemistry and staged by the absence (stage I) or presence of follicular dendritic cells (FDCs) (stage II) or germinal centers (GCs) (stage III). The outcome was response to immunosuppression, defined as no remission with up to 12 months of immunosuppression. RESULTS: Kidney interstitial TLTs were present in 429 of 845 patients with IgAN (50.8%), of whom 72 of 429 (16.8%) had TLTs at advanced stages (stage II or III). Compared with patients without TLTs, both the presence and stage of TLTs were associated with significantly increased risk of poor response to immunosuppression, with an adjusted odds ratio (95% confidence interval [CI]) of 3.07 (2.16-4.37), 2.97 (2.05-4.28), and 6.25 (3.39-11.53) in those with TLTs at any stage, stage I, and advanced stage, respectively. This grade association remained consistent across all prespecified subgroups. The stage and number of TLTs predicted poor response to immunosuppression with an area under receiver operating characteristic curve (AUC) of 0.81 (95% CI: 0.75-0.87). The AUC increased to 0.90 (95% CI: 0.87-0.94) when we combined TLTs with the clinical and glomerular macrophage data at biopsy. CONCLUSION: The presence of interstitial TLTs at diagnosis was associated with poor response to immunosuppression in IgAN.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Zhao H, Ma R, Zhong Z, et al. Kidney Tertiary Lymphoid Tissues and Poor Immunosuppressive Response in IgA Nephropathy. Kidney Int Rep. 2025. PMID: 41502802. doi:10.1016/j.ekir.2025.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。